Detalhe da pesquisa
1.
Trial of Pimavanserin in Dementia-Related Psychosis.
N Engl J Med
; 385(4): 309-319, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289275
2.
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.
Alzheimers Dement
; 20(3): 1839-1850, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145469
3.
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.
Alzheimers Dement
; 19(5): 1938-1946, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373344
4.
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
Alzheimers Dement
; 19(9): 4127-4138, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279390
5.
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
N Engl J Med
; 380(15): 1408-1420, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30970186
6.
Design and Development of a Community-Based, Interdisciplinary, Collaborative Dementia Care Program.
Am J Geriatr Psychiatry
; 30(6): 651-660, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34893448
7.
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.
Alzheimers Dement
; 18(12): 2687-2698, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35212149
8.
Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
Alzheimers Dement
; 18(11): 2272-2282, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103388
9.
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease.
N Engl J Med
; 378(18): 1691-1703, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719179
10.
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
Brain
; 143(12): 3816-3826, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253354
11.
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
Alzheimers Dement
; 16(11): 1483-1492, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33049114
12.
Brain imaging measurements of fibrillar amyloid-ß burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
Alzheimers Dement
; 16(4): 598-609, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31831374
13.
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial.
Alzheimers Dement
; 16(7): 1023-1030, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32418361
14.
GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
Alzheimers Dement
; 15(4): 515-524, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772251
15.
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
JAMA
; 319(2): 130-142, 2018 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318278
16.
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
PLoS Med
; 14(3): e1002254, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323826
17.
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Int Psychogeriatr
; 28(3): 503-10, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26478578
18.
Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 91(3): 330-332, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31874859
19.
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
JAMA
; 314(12): 1242-54, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26393847
20.
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
Alzheimers Dement
; 10(6): 666-74, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751827